Highlights

  • Actinogen Medical Ltd (ASX: ACW) traded at $0.043 as at 3:00pm AEST on August 7, 2026.
  • The stock recorded an increase of approximately 1.19 percent for the session based on the data reviewed.
  • Shares traded within an intraday range of $0.042 to $0.044.
  • Market capitalisation stood at approximately $158.14 million.
  • Trading volume reached 2,258,840 shares during the session.

Actinogen Medical Ltd (ASX: ACW) shares were trading at $0.043 as at 3:00pm AEST on August 7, 2026, after recording an increase of approximately 1.19 percent during the session. The stock traded within a narrow intraday range of $0.042 to $0.044, while the broader S&P/ASX 200 Health Care Index moved lower during the same period.

Actinogen Medical Share Price Movement on August 7, 2026

Actinogen Medical shares recorded an increase of approximately 1.19 percent for the session based on the reviewed market data. The stock traded between an intraday low of $0.042 and a high of $0.044.

For lower-priced stocks, small movements in absolute share price terms can result in relatively larger percentage changes. Therefore, the daily movement is considered alongside the underlying share price, trading range and market activity during the session.

Trading Volume and Market Capitalisation

Trading volume for Actinogen Medical reached 2,258,840 shares during the session. Based on the reported share price, the company’s market capitalisation stood at approximately $158.14 million.

The trading volume reflected market participation in the stock during the reviewed period, while the company’s market capitalisation placed it among the smaller-capitalisation companies within the ASX health care sector.

One-Year Share Price Performance

Over the trailing one-year period, Actinogen Medical recorded an increase of approximately 77.08 percent based on the data reviewed.

Companies operating within the clinical-stage biotechnology segment can experience share price movements influenced by company-specific developments, research and development progress, regulatory milestones and broader investor sentiment toward the biotechnology sector.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) was trading at 28,010.8 points, down 224.7 points or 0.80 percent, as at 3:20pm AEST on August 7, 2026, with the market session still open.

The index traded within an intraday range of 27,808.8 to 28,235.5 points against a previous close of 28,235.5. Over the past 52 weeks, the index ranged between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.37 percent.

Individual health care stocks can move differently from the broader index due to company-specific factors, trading volumes and changes in market participation.

About Actinogen Medical Ltd

Actinogen Medical Ltd is an Australian clinical-stage biopharmaceutical company listed on the ASX under the ticker code ACW and classified within the health care sector.

As with other companies operating in biotechnology, share price movements can vary from broader market trends depending on company-specific updates, sector sentiment and investor activity.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of Actinogen Medical’s market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the period, while market capitalisation reflects the company’s market value based on the reported share price and shares on issue. Daily share price movements can be influenced by multiple factors and represent activity during a specific trading period.

Conclusion

As at 3:00pm AEST on August 7, 2026, Actinogen Medical Ltd (ASX: ACW) shares were trading at $0.043, within a day range of $0.042 to $0.044, on trading volume of 2,258,840 shares and a market capitalisation of approximately $158.14 million.

The stock recorded an increase of approximately 1.19 percent during the session, while the broader S&P/ASX 200 Health Care Index traded lower. The reviewed data provides an overview of Actinogen Medical’s share price activity and market position within the ASX health care sector.